Long-term efficacy and safety of E/C/F/TDF vs EFV/FTC/TDF and ATV+RTV+FTC/TDF in HIV-1-infected treatment-naïve subjects ≥50 years

INTRODUCTION: In high-income countries, ≥30% of HIV-infected patients are ≥50 years (yrs) old (UNAIDS 2013). In two phases, three clinical trials (Studies 102 and 103) elvitegravir/cobicistat/emtricitabine/tenofovir DF (E/C/F/TDF; STB) had non-inferior efficacy and favourable safety vs efavirenz/emt...

Descripción completa

Detalles Bibliográficos
Autores principales: Gazzard, Brian, Marie Girard, Pierre, Di Perri, Giovanni, Gallant, Joel, Towner, William, Rogatto, Felipe, Demorin, Jennifer, McColl, Damian, Liu, Hui, Rhee, Martin, Szwarcberg, Javier, Piontkowsky, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Poster Sessions – Abstract P235
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225383/
https://www.ncbi.nlm.nih.gov/pubmed/25397511
http://dx.doi.org/10.7448/IAS.17.4.19767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225383/
https://www.ncbi.nlm.nih.gov/pubmed/25397511
http://dx.doi.org/10.7448/IAS.17.4.19767

Ejemplares similares